Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp has demonstrated strong performance in its healthcare segment, with double-digit growth for six consecutive quarters and a year-over-year increase of 14% in the first half of 2025. Furthermore, the company's organic sales have risen 5%, supported by the growth in four out of nine end markets that contribute to 40% of total sales, despite anticipated challenges in the consumer end market. The solid performance across diverse industries, primarily in the United States, positions Avient favorably for future revenue stability and growth.

Avient Corp has experienced a decline in organic sales, with a 2% drop reported in 1Q24, indicating potential difficulty in maintaining revenue momentum despite some sequential growth in subsequent quarters. Furthermore, demand in the chemical sector has been weakening since mid-2025, raising concerns about potential volume reductions in the second half of 2025. While a declining dollar could provide some short-term benefits, the overall weakening demand signals a challenging environment that could adversely impact Avient's financial performance.